Please use this identifier to cite or link to this item:
Title: Early experience with 68Ga-DOTATATE preparation
Authors: Saw, M.M. 
Issue Date: 2013
Citation: Saw, M.M. (2013). Early experience with 68Ga-DOTATATE preparation. Recent Results in Cancer Research 194 : 177-188. ScholarBank@NUS Repository.
Abstract: Neuroendocrine tumors (NETs) are a rare form of cancer. NETs frequently express cell membrane-specific peptide receptors, such as somatostatin receptors (SSTRs). Radiolabeled peptides bind to SSTR and provide in vivo histopathological information for diagnostic purposes. 68Ga-DOTATATE has higher sensitivity for low-grade tumors and greater avidity to well-differentiated NETs than 18F-FDG, being superior to 111In-DTPA-octreotide and 18F-DOPA in evaluation of well-differentiated metastatic NETs. The feasibility of 68Ga-DOTATATE application in routine clinical practice for PET imaging of NETs was determined in a limited number of known cases (n = 6). 68Ga-DOTATATE scan could detect all known sites of NETs and in one case previously unknown peritoneal metastasis. Early regulatory consideration is important for routine clinical use. © 2013 Springer-Verlag Berlin Heidelberg.
Source Title: Recent Results in Cancer Research
ISBN: 9783642279935
ISSN: 00800015
DOI: 10.1007/978-3-642-27994-2-10
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Page view(s)

checked on Sep 16, 2021

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.